Advances in Neurology, Contributions to Brain Health: Costantino Iadecola, MD


The director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine talked about brain health in relation to vascular health ahead of the 2023 AAN annual meeting. [WATCH TIME: 3 minutes]

WATCH TIME: 3 minutes

"Every country and every neurological or medical community is focused on brain health. They are continuously consensus statements coming from a variety of countries about what we should do to preserve brain health."

The 2023 American Academy of Neurology (AAN) Annual Meeting, April 22-27, in Boston, Massachusetts, is expected to comprise a broad range of topics in neurology, with community representation from the different subspecialities. The program is set up to be predominantly clinical, and geared toward clinician practice. During the meeting, there will be a variety of educational courses and sessions for clinicians to help them learn about the different topics related to neurological conditions.

Brain health with neurodegenerative diseases, specifically Alzheimer disease, will be among the topics discussed at the meeting. This will cover the latest developments in factors that contribute to damaging the brain, particularly the impact of vascular contributions. On the last day of the meeting, Costantino Iadecola, MD, will give a talk in one of the plenary sessions on advances in neurology about brain health. He plans to present evidence of the causes of brain damage and strategies to counteract threats to the brain.

Iadecola, the Ann Parish Titzell Professor of Neuroscience and director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, recently sat down with NeurologyLive® in an interview before the meeting to talk about his presentation in regard to the topic of brain health. He talked about the importance of vascular health in regard to the aging population, who are more at risk for brain diseases. He also spoke about the types of pathologies that cause damage in the brain and what clinicians should keep in mind with their patients.

Click here for more coverage on 2023 AAN.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.